Original document(79 pages) Authorized document(79 pages) 中文版
    The disclosure pertains to cascade polymer complexes containing the following: a) complex-forming ligands of general formula (I), in which A is a nitrogen-containing cascade nucleus of basic multiplicity a; X and Y independently of one another stand for a direct bond or a cascade reproduction unit of reproduction multiplicity x or y; Z and W independently of one another stand for cascade reproduction units of reproduction multiplicity z or w; K is the remainder of a complex forming agent; a stands for a number between 2 and 12; x, y, z and w independently of one another stand for numbers between 1 and 4, a condition being that at least two reproduction units are different and that the product of the multiplicities obeys the expression 16 <= a x y z w <= 64; b) at least 16 ions of an element of atomic number 20-29, 39, 42, 44 or 57-83; c) optionally cations of inorganic and/or organic bases, amino acids or amino acid amides; and d) optionally acylated terminal amino groups.
Application Number
申请号
96195200 Application Date
申请日
1996.06.20
Title 名称 Cascade polymer complexes, its preparation process and medicine containing cascade polymer
Publication Number
公开号
1189779 Publication Date
公开日
1998.08.05
Approval Pub. Date 2002.02.27 Granted Pub. Date 2002.02.27
International Classification 分类号 A61K49/00;A61K49/04;A61K49/12
Applicant(s) Name
申请人
Schering Aktiengesellschaft
Address 地址
Inventor(s) Name 发明人 Heribert Schmitt-Willich;Johannes Platzek;Bernd Radschel
Attorney & Agent 代理人 guo xiaodong

  
Intermediate for preparing cascade polymeric ligand and contrast medium
Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules
Conjugates of macrocyclic metal complexes with biomolucules and utilization thereof for producing agents for use in NMR diagnosis and radiodiagnosis and radiotherapy
Metal complexes of polyaminoacids, and their utilization in diagnostic imaging
Tissue adhesive using synthetic cross-linking agent
High-dose chromic tripicolinate for the treatment of type II diabetes
Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
Controlled release formulations for poorly soluble drugs
Sterile ophthalmological gel prepn. applicable in drops and processfor producing it
Diaminopyrazole-containing compositions for colouring keratin fibres, colouring process, novel diaminopyrazoles and method for their prepn.
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.